AFA-103
N/A
Report date: 2022/09/22 10:34:03
NME
Base Information
Drug NameAFA-103
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAfaSci Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A